These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4953644)

  • 1. Antitumor and hyperglycemic activity of streptozotocin (NSC-37917) and its cofactor, U-15,774.
    Evans JS; Gerritsen GC; Mann KM; Owen SP
    Cancer Chemother Rep; 1965 Oct; 48():1-6. PubMed ID: 4953644
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor activity and pharmacologic disposition of cytosine arabinoside (NSC-63878).
    Dixon RL; Adamson RH
    Cancer Chemother Rep; 1965 Oct; 48():11-6. PubMed ID: 5834734
    [No Abstract]   [Full Text] [Related]  

  • 3. [On some biological effects of the cytostatic agent verrucarin A].
    Rüsch ME; Stähelin H
    Arzneimittelforschung; 1965 Aug; 15(8):893-7. PubMed ID: 4955716
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.
    Heyes J; Catherall EJ; Cockburn A
    Cancer Chemother Rep; 1973; 57(3):263-8. PubMed ID: 4751253
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methodical aspects in studies on the carcinogenesis and chemotherapy of tumors].
    Schmähl D
    Planta Med; 1968; ():3-12. PubMed ID: 4976078
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mitoxantrone HCl (1,4-dihydroxy-4, 8-bis[[2-(hydroxyethyl)-amino-ethyl)]amino 9,10-anthracenedione dihydrochloride (NSC 301739) - a new cytostatic].
    Hagenberg L; Loynds P; Nagel GA
    Onkologie; 1980 Dec; 3(6):322-8. PubMed ID: 6784060
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of polyriboinosinic: polyribocytidylic acid, a new antiviral and antitumor agent.
    Adamson RH; Fabro S; Homan ER; O'Gara RW; Zendzian RP
    Antimicrob Agents Chemother (Bethesda); 1969; 9():148-52. PubMed ID: 4990370
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor activity of withaferin A (NSC-101088).
    Shohat B; Gitter S; Abraham A; Lavie D
    Cancer Chemother Rep; 1967 Sep; 51(5):271-6. PubMed ID: 6062297
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909).
    Emanuel NM; Vermel EM; Ostrovskaya LA; Korman NP
    Cancer Chemother Rep; 1974; 58(2):135-48. PubMed ID: 4830495
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of combinations of uracil mustard (NSC-34462) and 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) [KTS; NSC-82116] against murine tumors.
    Petering HG; Buskirk HH; Crim JA
    Cancer Chemother Rep; 1966 Nov; 50(8):557-64. PubMed ID: 5978728
    [No Abstract]   [Full Text] [Related]  

  • 11. 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196)--clinical brochure.
    Carter SK; Newman JW
    Cancer Chemother Rep 3; 1968 Dec; 1(1):63-80. PubMed ID: 4989815
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological properties and antitumor activity of a preparation diiodo-benzo-tepa in experiments].
    Trinus FP; Sologub PY; Protsenko LD; Tarnavskaya MI; Nikolaeva SV; Danilenko VS; Sharykina NI; Kolodyazhny VI; Zaikina RG; Goncharenko GV; Kopel'nik MA; Andrianova SM
    Vopr Onkol; 1979; 25(9):53-8. PubMed ID: 90429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the effect of tumor type and route of administration on the antitumor activity of the amino acid mimosine (NSC-69188).
    DeWys WD; Hall TC
    Cancer Chemother Rep; 1973 Feb; 57(1):41-9. PubMed ID: 4704102
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313).
    Németh L; Institóris L; Somfai S; Gál F; Pályi I; Sugár J; Csuka O; Szentirmay Z; Kellner B
    Cancer Chemother Rep; 1972 Oct; 56(5):593-602. PubMed ID: 4652589
    [No Abstract]   [Full Text] [Related]  

  • 15. Porfiromycin (NSC-56410)--clinical brochure.
    Carter SK
    Cancer Chemother Rep 3; 1968 Dec; 1(1):81-97. PubMed ID: 4989816
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental methodology for the selection of potential anticancer agents].
    Pérez Mínguez F; Llombart Bosch A
    Rev Esp Oncol; 1982; 29(4):593-602. PubMed ID: 6927364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and biological activity of 5-aminoimidazoles and 5-triazenoimidazoles.
    Shealy YF
    J Pharm Sci; 1970 Nov; 59(11):1533-58. PubMed ID: 4992995
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antineoplastic activity of L-asparaginase].
    Grgić Z
    Lijec Vjesn; 1969 Jul; 91(7):783-6. PubMed ID: 4910066
    [No Abstract]   [Full Text] [Related]  

  • 19. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
    Carter SK; Newman JW
    Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors.
    Dombernowsky P; Nissen NI; Larsen V
    Cancer Chemother Rep; 1972 Feb; 56(1):71-82. PubMed ID: 4624138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.